Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dispute resolution guidance

This article was originally published in The Tan Sheet

Executive Summary

Drug manufacturers are allotted 30 days to ask for clarification of a disputed scientific or technical issue under a guidance for industry on formal dispute resolution published in the Federal Register Jan. 12. The draft guidance, which was released in 2003, allowed only a 10-day period (1"The Tan Sheet" Sept. 8, 2003, p. 11). If FDA's Dispute Resolution Panel deems the issue worthy of review, the new guidance states the panel must schedule a meeting within 90 days of the request, rather than the indefinite amount of time allowed in the draft. The guidance also notes that during the process, "a manufacturer may include relevant information that was not presented during the inspection," as long as FDA determines that a reasonable explanation is given on why it was not presented during the inspection...
Advertisement

Related Content

FDA Drug GMP Dispute Resolution Guidance Allows 10 Days For Objections
FDA Drug GMP Dispute Resolution Guidance Allows 10 Days For Objections

Topics

Advertisement
UsernamePublicRestriction

Register

PS099001

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel